Path. Path will ship Products from its own warehouses to fill orders submitted to it by Rockford and will follow Rockford's established procedures for confirming to Rockford the quantities and dates of shipment (including submission of entries to Rockford's information systems) so that Rockford can timely invoice its Dealers. Path will not make any independent sales of the Products, but will:
Path. The connectivity in SEA-ME-WE 3 between any two Cable System Interfaces, independent of the actual physical links used to connect these Cable System Interfaces.
Path. This module is to let agents moving to destinations with the shortest path approach. (Price: USD 1M)
Path. The ‘path’-field should contain the HTML-File name that was automatically generated by the SpiderControl Editor. If this file is stored in a subdirectory relatively to the webservers root directory, this path information should be added here. Please use ‘/’ as separator. Do not show… If you select this checkbox, the above dialog will not appear the next time that you start the MicroBrowser. All the above configurations will be stored in a XML-file that is located in the working directory of the MicroBrowser. If you need to change the settings later, but the checkbox was already set before, this file can be edited with an editor or this dialog can be reopened with the shortcut ‘SHIFT-o’. XML Configuration File It is essential that the MicroBrowser can write, open and modify this file on the local file-system. The XML-File is called uBrowser.XML and is located in the installation directory of the MicroBrowser_CE.exe. The file can be edited with any ASCII-text editor. The contents of this file is as follows (contents may vary): 10 <?xml version="1.0" encoding="iso-8859-1"?> 11 <uBrowser> 12 <!--Configuration file of the micro-browser--> 13 <version>114</version> 14 <start_page>xxxx://000.0.000.00/Xxxxxx.xxxx</start_page> 15 <log_file>uBrowser.log</log_file> 16 <proxy_host></proxy_host> 17 <proxy_port>80</proxy_port> 18 <vpi_user></vpi_user>
Path. PATH is a non-profit with substantial funding from the Gates Foundation active in global vaccines initiatives. I am a consultant to PATH in regard to their initiative to secure a new vaccine for epidemic Group A meningitis in Sub-Saharan Africa. The project is a priority for GAVI and is joint between PATH, The World Health Organization and the US Centers for Disease Control and Prevention. I am both a technical advisor and a member of the committee negotiating with potential manufacturers. There are no regularly scheduled meetings of the meningitis task force. I believe my role will essentially end once PATH issues a contract.
Path. (i) Subrecipient name (which must match the name associated with its unique entity identifier); North Sound BH-ASO
Path. The connectivity in China-US CN between any two Cable Network Interfaces, independent of the actual links used to connect these Cable Network Interfaces. The Paths are as follows:
Path. The connectivity in the APCN 2 between any two Network Interfaces which is independent of the actual physical links used to connect these Network Interfaces.
Path. 1 shall, unless and until the Certificate is amended to reduce the Conversion Price of the Series B Preferred Stock to the initial Warrant Shares exercise price or lower, or until by operation of the Certificate as it stands the Conversion Price is reduced to the initial Warrant Shares exercise price or lower, treat (as to CC) the Conversion Price as being the initial Warrant Shares exercise price in the following manner: when and if CC converts any of its Series B Preferred Stock in accordance with the Certificate), then, if (i) the number of new shares of Path 1 Common Stock issued in such conversion is less than (ii) the number of new shares of Path 1 Common Stock which would have been issued to CC upon conversion of the same number of shares of Series B Preferred Stock if the Conversion Price in the Certificate were the initial Warrant Shares exercise price, then Path 1 shall promptly also issue to CC that exact number of new shares of Path 1 Common Stock that equals the difference between (i) above and (ii) above (all subject to adjustments for any stock splits, reverse stock splits, stock dividends on or recapitalizations of the Series B Preferred Stock).
Path. PATH is the leader in global health innovation. An international nonprofit organization, PATH saves lives and improves health, especially among women and children. Accelerating innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—PATH harnesses its entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, PATH takes innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. With these key partners, PATH delivers measurable results that disrupt the cycle of poor health. Learn more at xxx.xxxx.xxx.
